ABX 464 Aims to Reduce HIV Reservoirs
Revving Up
Investigational agent ABX 464 seeks to reduce HIV reservoirs
by Jeannie Wraight
ABX 464 is making its way through clinical trials, showing strong potential as…
PaxVax’s Vaccine Platform & Other Research Build Momentum
Gaining Momentum
HIV vaccine candidates seek to make good on their early promise
by Jeannie Wraight and David Miller
Over the past several years, momentum for the…
IV Drug Users & HIV Vaccine Response
Everyone Counts
Differences in intravenous drug users may affect their response to an HIV vaccine
by Jeannie Wraight
Prevention strategies such as Treatment as Prevention, PrEP, syringe…
HIV Remission Studies & Starting ARVs Early
Step by Step
At CROI 2017, HIV remission studies focus on early antiretroviral therapy initiation
by Jeannie Wraight
This year marked the 24th annual Conference on Retroviruses…
The New Administration & the Threat to HIV Care and Cure…
Buyer Beware
The new administration may threaten HIV care and cure research
by Jeannie Wraight
Our way of life in the U.S. has already drastically changed as…
amfAR Institute for HIV Cure Research: An Interview with Dr. Paul…
Hide & Seek
Paul Volberding, MD, helps create synergy at the amfAR Institute for Cure Research
by Jeannie Wraight
The amfAR Institute for HIV Cure Research was…
Targeting HIV Reservoirs
Hiding Place
One focus of the amfAR 2016 CURE Summit targeted HIV reservoirs
by Jeannie Wraight
This year, amfAR marked World AIDS Day with the 2016 HIV…
Broad Spectrum Antivirals: Part II
Beyond One Bug, One Drug
Broad spectrum antivirals shift the drug model paradigm, part II
by Jeannie Wraight
In the October issue of A&U, Destination: Cure explored…
Broad Spectrum Antivirals: Part I
Spectrum Analysis
Broad spectrum antivirals shift the drug model paradigm
by Jeannie Wraight
The recent spread of emerging pandemic viruses such as Zika and Ebola has increased…
HTVN 702: Vaccine Candidate
Step Forward
Vaccine candidates like HTVN 702 are needed to build momentum
by Jeannie Wraight
If current HIV diagnoses rates persist, about 1 in 2 black men…
LATEST POSTS
You Care About HIV Criminalization (You Just Don’t Know It Yet)
On Sunday, June 24, 2018, Visual AIDS participated in the NYC Pride March, distributing over 7,500 copies of a newly commissioned broadsheet project designed…
